Adma Biologics Stock Price Prediction
| ADMA Stock | USD 17.88 0.36 1.97% |
Momentum 54
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter 0.18 | EPS Estimate Current Year 0.6 | EPS Estimate Next Year 0.94 | Wall Street Target Price 25.6667 | EPS Estimate Current Quarter 0.155 |
Using ADMA Biologics hype-based prediction, you can estimate the value of ADMA Biologics from the perspective of ADMA Biologics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards ADMA Biologics using ADMA Biologics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards ADMA using crowd psychology based on the activity and movement of ADMA Biologics' stock price.
ADMA Biologics Short Interest
A significant increase or decrease in ADMA Biologics' short interest from the previous month could be a good indicator of investor sentiment towards ADMA. Short interest can provide insight into the potential direction of ADMA Biologics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 18.1969 | Short Percent 0.0972 | Short Ratio 6.52 | Shares Short Prior Month 18.6 M | 50 Day MA 17.4849 |
ADMA Biologics Hype to Price Pattern
Investor biases related to ADMA Biologics' public news can be used to forecast risks associated with an investment in ADMA. The trend in average sentiment can be used to explain how an investor holding ADMA can time the market purely based on public headlines and social activities around ADMA Biologics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of ADMA Biologics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about ADMA Biologics.
ADMA Biologics Implied Volatility | 0.73 |
ADMA Biologics' implied volatility exposes the market's sentiment of ADMA Biologics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ADMA Biologics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ADMA Biologics stock will not fluctuate a lot when ADMA Biologics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in ADMA Biologics to buy its stock at a price that has no basis in reality. In that case, they are not buying ADMA because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ADMA Biologics after-hype prediction price | USD 17.61 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current ADMA contract
Based on the Rule 16, the options market is currently suggesting that ADMA Biologics will have an average daily up or down price movement of about 0.0456% per day over the life of the 2026-03-20 option contract. With ADMA Biologics trading at USD 17.88, that is roughly USD 0.008158 . If you think that the market is fully incorporating ADMA Biologics' daily price movement you should consider acquiring ADMA Biologics options at the current volatility level of 0.73%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out ADMA Biologics Basic Forecasting Models to cross-verify your projections. ADMA Biologics After-Hype Price Prediction Density Analysis
As far as predicting the price of ADMA Biologics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ADMA Biologics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ADMA Biologics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ADMA Biologics Estimiated After-Hype Price Volatility
In the context of predicting ADMA Biologics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ADMA Biologics' historical news coverage. ADMA Biologics' after-hype downside and upside margins for the prediction period are 14.72 and 20.50, respectively. We have considered ADMA Biologics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ADMA Biologics is not too volatile at this time. Analysis and calculation of next after-hype price of ADMA Biologics is based on 3 months time horizon.
ADMA Biologics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ADMA Biologics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ADMA Biologics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ADMA Biologics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.43 | 2.89 | 0.27 | 0.26 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
17.88 | 17.61 | 1.51 |
|
ADMA Biologics Hype Timeline
ADMA Biologics is presently traded for 17.88. The entity has historical hype elasticity of -0.27, and average elasticity to hype of competition of 0.26. ADMA is expected to decline in value after the next headline, with the price expected to drop to 17.61. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.51%, whereas the daily expected return is presently at 0.43%. The volatility of related hype on ADMA Biologics is about 469.92%, with the expected price after the next announcement by competition of 18.14. About 95.0% of the company shares are held by institutions such as insurance companies. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 9 days. Check out ADMA Biologics Basic Forecasting Models to cross-verify your projections.ADMA Biologics Related Hype Analysis
Having access to credible news sources related to ADMA Biologics' direct competition is more important than ever and may enhance your ability to predict ADMA Biologics' future price movements. Getting to know how ADMA Biologics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ADMA Biologics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ACAD | ACADIA Pharmaceuticals | 0.37 | 10 per month | 1.65 | 0.12 | 4.25 | (2.94) | 11.93 | |
| PRAX | Praxis Precision Medicines | 14.06 | 10 per month | 3.24 | 0.17 | 13.25 | (6.81) | 197.04 | |
| BLTE | Belite Bio ADR | 0.52 | 9 per month | 2.49 | 0.29 | 9.61 | (5.94) | 19.48 | |
| LGND | Ligand Pharmaceuticals Incorporated | (4.25) | 10 per month | 1.43 | 0.03 | 3.36 | (2.54) | 12.78 | |
| SLNO | Soleno Therapeutics | (0.72) | 11 per month | 0.00 | (0.1) | 6.26 | (4.84) | 33.03 | |
| MIRM | Mirum Pharmaceuticals | (0.84) | 8 per month | 2.01 | 0.02 | 3.97 | (3.68) | 12.46 | |
| DYN | Dyne Therapeutics | (2.97) | 6 per month | 4.30 | 0.12 | 9.47 | (5.89) | 58.12 | |
| CRNX | Crinetics Pharmaceuticals | 0.16 | 8 per month | 2.51 | 0.05 | 4.38 | (5.14) | 16.20 | |
| TLX | Telix Pharmaceuticals Limited | 0.04 | 8 per month | 0.00 | (0.13) | 5.13 | (4.43) | 15.54 | |
| RARE | Ultragenyx | (0.22) | 11 per month | 0.00 | (0.03) | 5.49 | (3.92) | 51.23 |
ADMA Biologics Additional Predictive Modules
Most predictive techniques to examine ADMA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ADMA using various technical indicators. When you analyze ADMA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ADMA Biologics Predictive Indicators
The successful prediction of ADMA Biologics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ADMA Biologics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ADMA Biologics based on analysis of ADMA Biologics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ADMA Biologics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ADMA Biologics's related companies. | 2025 | 2026 (projected) | Dividend Yield | 0.0781 | 0.0694 | Price To Sales Ratio | 10.78 | 11.31 |
Story Coverage note for ADMA Biologics
The number of cover stories for ADMA Biologics depends on current market conditions and ADMA Biologics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ADMA Biologics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ADMA Biologics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ADMA Biologics Short Properties
ADMA Biologics' future price predictability will typically decrease when ADMA Biologics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ADMA Biologics often depends not only on the future outlook of the potential ADMA Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ADMA Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 243.3 M | |
| Cash And Short Term Investments | 103.1 M |
Complementary Tools for ADMA Stock analysis
When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |